NCT00476073View on ClinicalTrials.gov

Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

PHASE3CompletedINTERVENTIONAL

Enrollment

228

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Asthma Bronchiale

Interventions

DRUG

FLUTIFORM® (Formoterol fumarate / Fluticasone propionate)

Trial Locations (1)

Unknown

Dr Blagden, Chesterfield

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY

NCT00476073 - Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma | Biotech Hunter | Biotech Hunter